Abbott India LtdPharmaceuticalsINE358A01014Standalone₹27273.30+1363.20 (+5.26%)Jun-26
Valuation
Market Cap₹57.95K Cr
TTM PE35.89x
Forward PE36.24x
PEG0.99
Book Value₹1992.14
P/B13.69x
TTM EPS₹759.85
Fwd EPS₹752.57
TTM Revenue₹7.00K Cr
TTM PAT₹1.61K Cr
TTM EBITDA₹1.97K Cr
TTM EBIT₹1.89K Cr
Last Qtr PAT₹428.52 Cr
Last Qtr EBITDA₹522.50 Cr
Last Qtr EBIT₹502.75 Cr
Profitability
ROE38.14%
ROCE51.00%
TTM NPM23.05%
TTM EBITDA %28.11%
Curr OPM23.63%
Last OPM23.10%
Curr NPM—
Last NPM—
Curr EPS₹201.66
Last EPS₹185.85
Balance sheet
Equity₹21.25 Cr
Reserve₹4.21K Cr
Total Debt₹60.00 Cr
D/E0.01x
Interest %1.38%
Curr Interest₹5.91 Cr
Price / range
Close₹27270.00
vs 52W High-12.96%
vs 52W Low+8.49%
MA50—
MA200—
Returns
1D+5.25%
1W+6.59%
1M+2.58%
3M+4.35%
6M+3.71%
1Y-11.81%
2Y-1.89%
3Y+17.04%
5Y+33.15%
Diwali-4.27%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 1 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits